Holen Sie sich die Stockscreener-App
16.21
9.60%
1.42
Vorhandelsmarkt:
16.20
-0.01
-0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences - The Manila Times
Candlestick signals on Axogen Inc. stock todayPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted - MSN
Axogen Inc.’s volatility index tracking explainedQuarterly Market Summary & Low Risk High Reward Trade Ideas - Newser
Can Axogen Inc. hit a new high this monthSell Signal & Community Consensus Trade Alerts - Newser
Is Axogen Inc. stock entering bullish territory2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
Elliott Wave Theory Predicts Pullback in Axogen Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Why Is Axogen Stock Down 11% In Pre-Market Today? - MSN
Using data tools to time your Axogen Inc. exitJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
Will earnings trigger a reversal in Axogen Inc.Earnings Trend Report & Verified Entry Point Signals - Newser
Published on: 2025-08-26 08:58:25 - Newser
Health Stocks Stumble After Regulatory Setbacks Rattle The Sector - Finimize
Will Axogen Inc. bounce back from current supportJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
AxoGen: FDA extends PDUFA date for BLA for Avance Nerve Graft to December 5 - MSN
What high frequency data says about Axogen Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Axogen Inc. Recovery Likely Here’s What Data ShowsWeekly Earnings Recap & Risk Controlled Daily Plans - 더경남뉴스
What's Driving Axogen’s Sudden Intraday Dive? - AInvest
Axogen (AXGN.O) Sees Sharp Intraday Drop: Technical, Order-Flow, and Peer Clues Point to Short-Term Selling Pressure - AInvest
Raymond James reiterates Outperform rating on AxoGen stock despite FDA delay - Investing.com Nigeria
Axogen (AXGN.O) Plummets 8.3%: What's Behind the Sharp Intraday Drop? - AInvest
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months - uk.finance.yahoo.com
FDA Extends Review for AxoGen’s Avance Nerve Graft - TipRanks
How hedge fund analytics apply to Axogen Inc. stock2025 Short Interest & Growth Focused Entry Point Reports - Newser
Axogen stock falls after FDA extends PDUFA date for Avance Nerve Graft - Investing.com Australia
Historical volatility pattern of Axogen Inc. visualized2025 Sector Review & Weekly High Conviction Ideas - Newser
Axogen Shares Fall Premarket as FDA Extends Avance Review - MarketScreener
Why Is Axogen Stock Down 15% In Pre-Market Today? - Stocktwits
FDA extends review period for Axogen’s nerve graft application By Investing.com - Investing.com Canada
Axogen Plunges 16.42% on Regulatory Delay - AInvest
FDA extends review period for Axogen’s nerve graft application - Investing.com
Axogen, Inc. Receives FDA Extension for Avance® Nerve Graft Biologics License Application Review - Quiver Quantitative
AxoGen: FDA extends PDUFA goal date to Dec 5, 2025 - AInvest
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft - GlobeNewswire
FDA Pushes Axogen's Groundbreaking Nerve Graft Review to December Following New Manufacturing Data - Stock Titan
Sector ETF performance correlation with Axogen Inc.Trade Volume Summary & Consistent Profit Alerts - Newser
Analyzing Axogen Inc. with risk reward ratio chartsWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
Why Axogen Inc. stock attracts strong analyst attentionWeekly Earnings Recap & Low Drawdown Momentum Ideas - Newser
Axogen Inc. Rebounds From Oversold Zone — Now What2025 Price Momentum & Capital Efficiency Focused Ideas - beatles.ru
Axogen Inc. stock retracement – recovery analysisBuy Signal & Fast Exit/Entry Strategy Plans - Newser
Applying chart zones and confluence areas to Axogen Inc.Quarterly Portfolio Report & Verified Momentum Stock Watchlist - Newser
What’s the analyst consensus on Axogen Inc.2025 Big Picture & Weekly Momentum Stock Picks - theviewers.co.kr
Full technical analysis of Axogen Inc. stockWeekly Profit Report & Fast Moving Stock Watchlists - Newser
Aug Drivers: What chart patterns are forming on Axogen Inc.2025 Earnings Impact & AI Forecasted Entry/Exit Points - theviewers.co.kr
Traders Consider Averaging Down in Axogen Inc.Portfolio Gains Report & Risk Adjusted Swing Trade Ideas - beatles.ru
When Can We Expect A Profit From Axogen, Inc. (NASDAQ:AXGN)? - simplywall.st
Will Axogen Inc. outperform its industry peers2025 Geopolitical Influence & Free Community Consensus Stock Picks - theviewers.co.kr
Is Axogen Inc. likely to announce a buybackQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - theviewers.co.kr
Can Axogen Inc. weather a recession2025 Key Highlights & Expert Verified Movement Alerts - theviewers.co.kr
Aug Fed Impact: Can Axogen Inc. grow without external funding2025 Price Momentum & Free High Accuracy Swing Entry Alerts - theviewers.co.kr
Axogen Inc. Breakout Confirmed by Volume MetricsJuly 2025 Highlights & Free High Accuracy Swing Entry Alerts - 더경남뉴스
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin - Yahoo Finance
Is Axogen Inc. stock bottoming outJobs Report & Verified Swing Trading Watchlist - Newser
How to track smart money flows in Axogen Inc.Weekly Profit Summary & Fast Moving Stock Watchlists - Newser
Chart based exit strategy for Axogen Inc.Bond Market & Free Community Consensus Stock Picks - Newser
AxoGen price target lowered to $20 from $21 at Raymond James - MSN
Leading vs lagging indicators on Axogen Inc. performanceQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
How Axogen Inc. stock performs during market volatility - sundaytimes.kr
Can Axogen Inc. grow without external funding2025 Market Overview & Expert-Curated Trade Recommendations - classian.co.kr
Does Axogen Inc. fit your quant trading modelEntry Point & Advanced Technical Signal Analysis - Newser
Tools to assess Axogen Inc.’s risk profileMarket Weekly Review & Expert Curated Trade Ideas - Newser
Short interest data insights for Axogen Inc.Watch List & Fast Entry Momentum Alerts - Newser
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21 - MSN
0.86%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):